September 18, 2025
September 10, 2025
July 3, 2025
January 10, 2025
Invicta Diagnostic Limited IPO | Important Dates, Price, and More
Author
Shoonya Team
Invicta Diagnostic Ltd. is launching an IPO of ₹28.12 crore, opening for subscription on December 1, 2025, and closing on December 3, 2025. The shares will be listed on the NSE SME, with a tentative listing date of December 8, 2025.
This IPO is entirely a fresh issue of 33,08,800 shares, aggregating up to ₹28.12 crore.
The price band is ₹80 – ₹85 per share, and the minimum lot size is 1,600 shares. For retail investors, the minimum investment is 2 lots (3,200 shares), totalling ₹2,72,000 at the upper price band. In comparison, sNII investors must apply for at least 4,800 shares (₹4,08,000), while bNII investors are required to apply for a minimum of 12,800 shares (₹10,88,000).
Here are the quick steps to apply for the Invicta Diagnostic Limited IPO!
Invicta Diagnostic Limited | IPO Details
| Detail | Information |
| IPO Opening Date | December 1, 2025 |
| IPO Closing Date | December 3, 2025 |
| Tentative IPO Listing Date | December 8, 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹80 – ₹85 per share |
| Lot Size | 1,600 shares |
| Total Issue Size | 33,08,800 shares (₹28.12 Cr) |
| Fresh Issue | 33,08,800 shares |
| IPO Segment | SME – Book Building |
| Listing At | NSE SME |
| Shareholding Pre-Issue | 92,63,173 shares |
| Shareholding Post-Issue | 1,25,71,973 shares |
Invicta Diagnostic Limited IPO | Company Overview
Invicta Diagnostic Ltd. was incorporated in 2021. It provides integrated radiology and pathology services under the brand PC Diagnostics. The company operates through 7 diagnostic centres and a central lab across Mumbai and the Mumbai Metropolitan Region, following a hub-and-spoke model.
The network includes a flagship hub in Thane West offering full-spectrum pathology and advanced radiology such as PET CT and MRI, along with three additional hubs in Bhayandar, Byculla, and Marol that provide specialised diagnostic services, and three spokes in Lower Parel, Sewri, and Kalwa focused on basic imaging and sample collection.
The company offers a comprehensive range of tests, including 60 routine pathology tests, 487 specialised pathology tests, 96 basic radiology tests, and 130 advanced radiology tests, supported by a home sample collection network.
As of October 31, 2025, Invicta Diagnostic employed 157 permanent staff.
Don’t miss the chance to invest in the Invicta Diagnostic Limited IPO. Open a free Demat account!
Invicta Diagnostic Limited IPO | Key Details
- IPO Opening Date: December 1, 2025
- IPO Closing Date: December 3, 2025
- Allotment Date: December 4, 2025
- Price Band: ₹80 – ₹85 per share
- IPO Size: ₹28.12 Crores (Fresh Issue)
- Refunds Initiated: December 5, 2025
- Shares Credited to Demat: December 5, 2025
- Listing Date: December 8, 2025
- Cut-off Time for UPI Mandate Confirmation: 5 PM on December 3, 2025
Invicta Diagnostic Limited IPO | Financial Overview
Invicta Diagnostic delivered strong growth, with revenue rising 90% YoY and profit after tax increasing 30% between FY24 and FY25.
Below is a snapshot of its financial performance:
Amounts are in ₹ Crore.
| Detail | 31-Mar-25 | 31-Mar-24 | Change (FY25 vs FY24) | Change % |
| Assets | 21.22 | 15.89 | +5.33 | +33.54% |
| Total Income | 30.18 | 15.90 | +14.28 | +89.81% |
| Profit After Tax | 4.93 | 3.81 | +1.12 | +29.39% |
| EBITDA | 9.20 | 7.09 | +2.11 | +29.74% |
| Net Worth | 13.60 | 8.67 | +4.93 | +56.84% |
| Reserves & Surplus | 5.18 | 8.54 | –3.36 | –39.34% |
| Total Borrowing | 3.54 | 3.81 | –0.27 | –7.09% |
Invicta Diagnostic Limited IPO | FAQs
The Invicta Diagnostic IPO opens on December 1, 2025, and closes on December 3, 2025.
The Invicta Diagnostic IPO price band is ₹80 – ₹85 per share. The minimum lot size is 1,600 shares, and retail investors must apply for 3,200 shares (2 lots).
You can apply for the Invicta Diagnostic IPO through any stockbroker’s app, ASBA net banking, or UPI mandate. Select Invicta Diagnostic IPO, choose the lot size, submit your bid, and approve the UPI mandate.
Refunds for the Invicta Diagnostic IPO will be processed on December 5, 2025, and shares will be credited to Demat accounts the same day.
The face value of shares offered in the Invicta Diagnostic IPO is ₹10 per share.
The Invicta Diagnostic IPO consists of a fresh issue of 33,08,800 shares, totalling ₹28.12 Crores.
The promoters of the Invicta Diagnostic IPO are Dr. Ketan Jayantilal Jain, Dr. Sanket Vinod Jain, Rohit Prakash Srivastava, Badal Kailash Naredi, and Jayesh Prakash Jain.
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.
Explore Our Offerings
Stocks
Trade equities across NSE and BSE with zero delivery charges. Invest, hold or sell with a seamless experience.
Future & Options
Execute complex strategies with simple tools and real-time data.
IPOs
Apply to the latest IPOs in just a few taps. Stay updated and capture opportunities as they open.